GlassScriptPhysician profile
Marwan Kazimi
NPI 1235302415
$32,694.32
in general payments reported to CMS, 2019-2025
20 companies · $2,843 in 2025
The $2,843 reported for 2025 was more than what 85% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $409 · 2021: $4,099 · 2022: $4,534 · 2023: $6,436 · 2024: $2,527 · 2025: $2,843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,952 · Consulting Fee: $3,003 · Food and Beverage: $2,722 · Education: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,951.92 |
| Consulting Fee | $3,003.00 |
| Food and Beverage | $2,722.48 |
| Education | $128.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $11,992.96 | 2020-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, General - Interventional Oncology, Exalt Model D |
| Biocompatibles, INC. | $11,377.21 | 2019 | |
| Transmedics, INC. | $5,292.62 | 2023-2024 | Organ Care System |
| La Jolla Pharmaceutical Company | $2,328.00 | 2023 | Giapreza |
| Organox LTD | $274.87 | 2025 | |
| Intuitive Surgical, INC. | $266.09 | 2023-2025 | Da Vinci Surgical System |
| Erbe USA INC | $216.10 | 2021 | |
| Ethicon US, LLC | $172.92 | 2019-2024 | Echelon Flex, Evarrest, Vistaseal |
| Healthmyne, INC. | $159.25 | 2019 | |
| Delcath Systems | $148.44 | 2024 | Hepzato Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $125.66 | 2019-2020 | |
| Histosonics, INC. | $89.44 | 2025 | |
| Angiodynamics, INC. | $46.61 | 2021 | |
| Baxter Healthcare | $41.79 | 2020 | |
| Stryker Corporation | $41.18 | 2024 | 1788 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $38.95 | 2019 | |
| Intercept Pharmaceuticals, INC. | $30.16 | 2019-2020 | |
| Kadmon Pharmaceuticals LLC | $21.35 | 2020 | |
| Abbvie INC. | $18.98 | 2019 | |
| W. L. Gore & Associates, INC. | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marwan Kazimi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.